Lab Information

Emily McDonald (MD/MSc)

Scientist
Centre for Outcomes Research and Evaluation
Department of Medicine (McGill)

Research Profile

 Fundamental: 50%
 Clinical: 0%
 Epidemiology: 50%
 Evaluation: 0%
 This email address is being protected from spambots. You need JavaScript enabled to view it.

Keywords

Quality improvement • patient safety • infection

Research Interests

My research focuses on interventions related to polypharmacy, safe and effective prescribing, and medication rationalization. A number of my studies relating to the appropriate use of hospital resources, tests and investigations have been published in high impact peer-reviewed journals and several relating to safer prescribing in older adults were featured recently in the media. I supervise postgraduate students in the field of medication safety and have received funding from the CIHR, the Centre for Ageing and Brain Health Innovation, the Canadian Frailty Network and, locally, from the McGill Interdisciplinary Initiative in Infection and Immunity (MI-4).


Team Members

Name Position

Latest Publications

  1. Lee, T. C., Murthy, S., Del Corpo, O., Senécal, J., Butler-Laporte, G., Sohani, Z. N., Brophy, J. M. & McDonald, E. G. (2022). Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
  2. Moryousef, J., Bortolussi-Courval, É., Podymow, T., Lee, T. C., Trinh, E. & McDonald, E. G. (2022). Deprescribing Opportunities for Hospitalized Patients With End-Stage Kidney Disease on Hemodialysis: A Secondary Analysis of the MedSafer Cluster Randomized Controlled Trial. Canadian journal of kidney health and disease, vol. 9, p. 20543581221098778.
  3. Spellberg, B., Aggrey, G., Brennan, M. B., Footer, B., Forrest, G., Hamilton, F., Minejima, E., Moore, J., Ahn, J., Angarone, M., Centor, R. M., Cherabuddi, K., Curran, J., Davar, K., Davis, J., Dong, M. Q., Ghanem, B., Hutcheon, D., Jent, P., Kang, M., Lee, R., McDonald, E. G., Morris, A. M., Reece, R., Schwartz, I. S., So, M., Tong, S., Tucker, C., Wald-Dickler, N., Weinstein, E. J., Williams, R., Yen, C., Zhou, S., Lee, T. C. & WikiGuidelines Group (2022). Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults: A WikiGuidelines Group Consensus Statement. JAMA network open, vol. 5, p. e2211321.
  4. Lee, T. C., Morris, A. M., Schwartz, I. S. & McDonald, E. G. (2022). Allocated but not treated: the silent 16. Lancet (London, England), vol. 399, p. 1775.
  5. Bai, A. D., Lo, C. K. L., Komorowski, A. S., Suresh, M., Guo, K., Garg, A., Tandon, P., Senecal, J., Del Corpo, O., Stefanova, I., Fogarty, C., Butler-Laporte, G., McDonald, E. G., Cheng, M. P., Morris, A. M., Loeb, M. & Lee, T. C. (2022). What Is the Optimal Follow-up Length for Mortality in Staphylococcus aureus Bacteremia? Observations From a Systematic Review of Attributable Mortality. Open forum infectious diseases, vol. 9, p. ofac096.
  6. Lee, T. C., Vigod, S., Bortolussi-Courval, É., Hanula, R., Boulware, D. R., Lenze, E. J., Reiersen, A. M. & McDonald, E. G. (2022). Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-analysis. JAMA network open, vol. 5, p. e226269.
  7. Bai, A. D., Lo, C. K., Komorowski, A. S., Suresh, M., Guo, K., Garg, A., Tandon, P., Senecal, J., Del Corpo, O., Stefanova, I., Fogarty, C., Butler-Laporte, G., McDonald, E. G., Cheng, M. P., Morris, A. M., Loeb, M. & Lee, T. C. (2022). Staphylococcus aureus bacteremia mortality: A systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
  8. Bai, A. D., Lo, C. K. L., Komorowski, A. S., Suresh, M., Guo, K., Garg, A., Tandon, P., Senecal, J., Del Corpo, O., Stefanova, I., Fogarty, C., Butler-Laporte, G., McDonald, E. G., Cheng, M. P., Morris, A. M., Loeb, M. & Lee, T. C. (2022). How generalizable are randomized controlled trials (RCTs) in Staphylococcus aureus bacteremia? A description of the mortality gap between RCTs and observational studies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
  9. Lee, T. C., Morris, A. M., Grover, S. A., Murthy, S. & McDonald, E. G. (2022). Outpatient Therapies for COVID-19: How Do We Choose?. Open forum infectious diseases, vol. 9, p. ofac008.
  10. Lee, T. C., Bortolussi-Courval, É., Belga, S., Daneman, N., Chan, A. K., Hanula, R., Ezer, N. & McDonald, E. G. (2022). Inhaled corticosteroids for outpatients with Covid-19: a meta-analysis. The European respiratory journal, vol. 59.
More on PubMed 



See also

Card image
Todd
Lee


See profile
Card image
Matthew
Cheng


See profile
Card image
Évelyne
Vinet


See profile
Card image
Nandini
Dendukuri


See profile
Card image
Sasha
Bernatsky


See profile
Card image
Donald
Sheppard


See profile